Form 4: LMAT Director Sells Shares After Option Exercise

Lemaitre Vascular President and Director David B. Roberts exercised stock options and subsequently sold an equivalent number of shares.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular Inc. (LMAT), engaged in transactions on August 11, 2025.
• Roberts exercised stock options to acquire a total of 10,815 shares of common stock.
• These acquisitions included 3,979 shares at $37.29, 123 shares at $35.48, and 6,713 shares at $37.29.
• Concurrently, Roberts sold a total of 10,815 shares of common stock.
• Sales included 3,718 shares at a weighted average price of $92.5337, 384 shares at $91.5484, and 6,713 shares at $92.3549.
• Following these transactions, Roberts directly beneficially owns 17,976 shares of common stock.
• Roberts also holds remaining stock options for 12,057 shares.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant sale of shares by a high-ranking insider, which often signals a lack of strong conviction in immediate future stock price appreciation, despite being a common practice for liquidity or tax planning.

Positives

• Exercise of stock options indicates a realization of value from long-term incentives.
• The exercise prices ($35.48, $37.29) are significantly lower than the sale prices (around $91-$92), indicating a substantial profit for the insider.

Negatives

• The sale of 10,815 shares by a key insider (President and Director) could be perceived negatively by the market, as it reduces their direct equity stake.
• The sale of shares immediately following option exercise often suggests a liquidity event rather than increased confidence in future stock price appreciation.

Future Outlook

NA

Industry Context

This filing reflects a routine insider transaction within the medical device industry, specifically for a company focused on vascular products. Such transactions are common for executives realizing value from long-term equity compensation.

Related Party Transactions

• David B. Roberts, President and Director, exercised stock options and sold shares of Lemaitre Vascular Inc. common stock.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal of reduced confidence, potentially leading to negative sentiment or downward pressure on the stock price.
• Employees: No direct impact mentioned, but general market sentiment can indirectly affect employee morale or stock-based compensation value.

Key Dates

Recommendation

While the insider sale by the President and Director might raise some concerns about future stock performance, it's a common practice for executives to monetize vested options for personal liquidity or diversification. The company's underlying business fundamentals are not addressed in this filing, so a "hold" recommendation is appropriate, suggesting investors monitor future company performance and broader market conditions rather than reacting solely to this insider transaction.

Keywords

Lemaitre Vascular, LMAT, Insider Trading, Form 4, Stock Options, Share Sale, Director Transaction, David B. Roberts, Medical Devices, Vascular